SANOFI CONSUMER HEALTHCARE INDIA
Quarterly Results Analysis [Jun2025]
SANOFI CONSUMER HEALTHCARE INDIA Quarterly Results
Standalone | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹221 Cr | ₹173 Cr | ₹171 Cr | ₹160 Cr | ₹172 Cr | ₹222 Cr | ₹225 Cr | ₹210 Cr |
Expenses | ₹151 Cr | ₹109 Cr | ₹109 Cr | ₹97 Cr | ₹109 Cr | ₹140 Cr | ₹135 Cr | ₹116 Cr |
Operating Income | ₹70 Cr | ₹64 Cr | ₹62 Cr | ₹63 Cr | ₹64 Cr | ₹82 Cr | ₹90 Cr | ₹95 Cr |
Other Income | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr |
Interest | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹79 Cr | ₹67 Cr | ₹63 Cr | ₹61 Cr | ₹39 Cr | ₹84 Cr | ₹90 Cr | ₹95 Cr |
Profit After Tax | ₹61 Cr | ₹50 Cr | ₹44 Cr | ₹45 Cr | ₹29 Cr | ₹63 Cr | ₹68 Cr | ₹71 Cr |
EPS | ₹26.39 | ₹21.74 | ₹19.26 | ₹19.57 | ₹12.61 | ₹313.50 | ₹27.16 | ₹30.96 |
Industry Peers & Returns | 1W | 1M | 1Y |
SANOFI CONSUMER HEALTHCARE INDIA | -1.1% | -1% | NA |
SUN PHARMACEUTICAL INDUSTRIES | 0.7% | 0.4% | -12.5% |
DIVIS LABORATORIES | -1.7% | 2% | 16.7% |
CIPLA | -0.9% | 5.3% | -3.7% |
TORRENT PHARMACEUTICALS | -0.1% | 0.6% | 6.6% |
DR REDDYS LABORATORIES | 4.1% | 7.6% | -3% |
MANKIND PHARMA | 1.7% | 5.8% | 6.8% |
ZYDUS LIFESCIENCES | 2.7% | 11.1% | -5.8% |
LUPIN | 2% | 3.2% | -13.2% |
SANOFI CONSUMER HEALTHCARE INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 27.98 % |
Y-o-Y | 28.21 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹221 Cr | 27.98 | |
Mar2025 | ₹173 Cr | 1.11 | |
Dec2024 | ₹171 Cr | 6.75 | |
Sep2024 | ₹160 Cr | -7.20 | |
Jun2024 | ₹172 Cr | -22.25 | |
Mar2024 | ₹222 Cr | -1.34 | |
Dec2023 | ₹225 Cr | 6.80 | |
Sep2023 | ₹210 Cr | - |
SANOFI CONSUMER HEALTHCARE INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9.69 % |
Y-o-Y | 10.38 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹70 Cr | 9.69 | |
Mar2025 | ₹64 Cr | 3.06 | |
Dec2024 | ₹62 Cr | -1.58 | |
Sep2024 | ₹63 Cr | -0.79 | |
Jun2024 | ₹64 Cr | -22.25 | |
Mar2024 | ₹82 Cr | -8.60 | |
Dec2023 | ₹90 Cr | -5.39 | |
Sep2023 | ₹95 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -14.29 % |
Y-o-Y | -13.90 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 31.78% | -14.29 | |
Mar2025 | 37.08% | 1.92 | |
Dec2024 | 36.38% | -7.81 | |
Sep2024 | 39.46% | 6.91 | |
Jun2024 | 36.91% | 0.00 | |
Mar2024 | 36.91% | -7.38 | |
Dec2023 | 39.85% | -11.41 | |
Sep2023 | 44.98% | - |
SANOFI CONSUMER HEALTHCARE INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 21.40 % |
Y-o-Y | 109.31 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹61 Cr | 21.40 | |
Mar2025 | ₹50 Cr | 12.87 | |
Dec2024 | ₹44 Cr | -1.56 | |
Sep2024 | ₹45 Cr | 55.17 | |
Jun2024 | ₹29 Cr | -53.75 | |
Mar2024 | ₹63 Cr | -7.66 | |
Dec2023 | ₹68 Cr | -4.63 | |
Sep2023 | ₹71 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -5.14 % |
Y-o-Y | 63.28 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 27.48 % | -5.14 | |
Mar2025 | 28.97 % | 11.64 | |
Dec2024 | 25.95 % | -7.78 | |
Sep2024 | 28.14 % | 67.20 | |
Jun2024 | 16.83 % | -40.51 | |
Mar2024 | 28.29 % | -6.42 | |
Dec2023 | 30.23 % | -10.72 | |
Sep2023 | 33.86 % | - |
SANOFI CONSUMER HEALTHCARE INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 21.39 % |
Y-o-Y | 109.28 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹26.39 | 21.39 | |
Mar2025 | ₹21.74 | 12.88 | |
Dec2024 | ₹19.26 | -1.58 | |
Sep2024 | ₹19.57 | 55.19 | |
Jun2024 | ₹12.61 | -95.98 | |
Mar2024 | ₹313.5 | 1,054.27 | |
Dec2023 | ₹27.16 | -12.27 | |
Sep2023 | ₹30.96 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD